We studied the effects of bile acids on inducibility of the transcription factor AP-1 in human colon carcinoma LoVo cells. Firstly, cells were treated with chenodeoxycholic acid and the nuclear extracts from those cells were processed by electrophoretic mobility shift assays to analyze nuclear AP-1 DNA-binding activity. We demonstrated that chenodeoxycholic acid induced AP-1 DNA-binding activity in a dose-and time-dependent fashion. Antibody supershift experiments clearly revealed that the majority of protein components in induced AP-1 DNA-binding activity were the products of oncogenes c-fos and c-jun. On the other hand, DNA-binding activity in the nuclear extracts for either NFKB, Spl, or ATF/CREB was not affected by bile acids, suggesting that the effect of bile acids was rather specific for AP-1. Transient transfection experiments supported this notion: expression of the AP-1-luciferase reporter construct was induced by bile acids in a dosedependent manner, and expression of either reporter construct for NFKB, Spl, or ATF/CREB was not influenced by treatment of the cells with bile acids. We also demonstrated that those bile acids efficiently activated AP-1-dependent promoter in DLD-1 cells, which (as well as LoVo cells), are derived from colon adenocarcinoma, but not in COLO320DM cells which are from colon carcinoid tumor. Thus, we may indicate that bile acids exclusively induce nuclear AP-1 activity in colon adenocarcinoma cells.
Introduction
Colon carcinogenesis appears to proceed through distinct stages of initiation and promotion (1). There is a large body of evidence implicating bile acids, which are normally present in the gastrointestinal tract, in the causation of colorectal cancer and this comes from: (a) tissue culture, microbial mutagenesis and animal studies of carcinogenesis/mutagenesis; (b) studies of human populations and of high risk patient groups; and (c) studies in humans of the toxicity of bile acids for the intestinal mucosa (2-7). Thus, bile acids have been shown to act as tumor promoters in colon carcinogenesis in vivo and to enhance cell transformation in vitro, and they appear to be endogenous
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It is well established that the mechanisms of tumor promotion are closely related to signal transduction and the action of specific oncogenes (8) . Tumor-promoter phorbor esters activate protein kinase C (PKC*), a Ca 2+ -activated, phospholipiddependent enzyme which plays a key role in growth-signaling pathways (8) . Potent phorbor esters such as phorbor 12-myristate 13-acetate (PMA) substitute for diacylglycerol, the physiological effector of the enzyme, by interacting with the same binding sites (8) . It is well documented that treatment of cells with PMA activates and down-regulates PKC and transiently induces the early-responsive c-fos and c-jun protooncogenes in association with the transition of cells into S phase (8) (9) (10) . Induction of the expression of c-fos and c-jun also results in the activation of AP-1 transcription factor, a heterodimeric protein complex composed of the products of members of the fas and jun gene family; to enhance its affinity for target DNA sequences and alter the expression of various genes (9, 10) . Many of the genes in this family are expressed in transformed rapidly-growing cells (9, 10) .
A number of studies have revealed that bile acids activate PKC in both normal colon epithelial cells and colon cancer cells (11-13). The fact that PKC activity is present at reduced levels in human colon carcinomas when compared to their normal adjacent colon mucosa (14-17), indicates down-regulation of this enzyme in transformed cells. At diis moment, it still remains unknown which nuclear signal is coupled with activation of PKC by bile acids. In the present study, we addressed this issue using colon carcinoma cell lines and revealed that bile acids activated both DNA-binding and transcriptional activation function of AP-1.
Materials and methods

Cells and culture
Monolayer cultures of human colon cancer cell lines LoVo, DLD-1 and COLO320DM were initiated from cells obtained from the Japanese Cancer Resource Bank. The LoVo line was established from a well-differentiated adenocarcinoma of metastatic tumor from supraclavicular lymph nodes (18, 19) . The DLD-1 line was established from a moderately to poorly differentiated adenocarcinoma of the sigmoid colon (20-22). The COLO320DM line was established from a poorly differentiated carcinoid of the sigmoid colon, and was derived from neuroendocrine origin (23) . LoVo cells were maintained in Ham's F12 (Gibco BRL, Grand Island, NY). DLD-1 and COLO320DM cells were maintained in RPMII640 (Gibco BRL). These culture media were supplemented with 10% heat-inactivated fetal calf serum (FCS) (Gibco BRL), 100 U/ml penicillin and 100 Ug/ml streptomycin. Serum steroids were stripped with dextran-coated charcoal before use. Cultures were serum-starved by growth in Ham's F12 or RPMI164O supplemented with antibiotics and 0.2% lactoalbumin hydrolysate for 4$ h before experiments. In all experiments, cells were cultured in a humidified atmosphere at 37°C with 5% CO2 unless otherwise specified.
Reagents and antibodies
Sodium salts for ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) were kindly gifted from Tokyo Tanabe Co. (Japan), and sodium salts for cholic acids (CA), deoxycholic acid (DCA), and lithocholic acid (LCA) FJUrano et al.
were purchased from Sigma Chemical Co. (St Louis, MO). These bile acids were dissolved in ethanol. Gas chromatography demonstrated that composition of all bile acids had a purity of at least 99.5%. PMA was purchased from Sigma Chemical Co. and was dissolved in ethanol. Antibodies against c-Fos, c-Jun and NFKB (RelA/p65) were commercially obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Plasmid construction
Various luciferase reporter plasmids used in the present study were constructed as follows. Oligonucleotides were synthesized on a DNA synthesizer. The sequences of the oligonucleotides used to detect the DNA binding activities of AP-1, NFKB, Spl, and ATF/CREB were the following: AP-1 = 5'-TAAAAAAGCATGAGTCAGACACCTGAGCT-3' (24); NFKB = 5'-AAGGGACTITCCGCTGGGGACTTTCCAG-3' (25); Spl = 5'-GGGACX3CGTCHjCCTCKX}CGGGACTGGGGAGTGGCGAGCT-3' (25); and ATF/CREB = 5'-GGGGGAAGTGACGTCACGT-3' (26) .
These oligonucleotides were annealed to their complementary oligonucleotides and tandemly ligated. The ligated AP-1 and Spl oligonucleotides were directly cloned into the Sac I site in the polylinker region of pUC119. The NFKB oligonucleotide was inserted into the blunt-ended Sac I site of pUC 119. The ATF/CREB oligonucleotide was inserted into the Sma I site of pUC119. The resultant plasmids were putatively designated as pUCAP-1, pUCSpl, pUCNFKB, and pUCATF/CREB, respectively. Insertion of the ligated oligonucleotide was verified by sequencing, which revealed that they contained five copies of AP-1, four copies of NFKB, six copies of Sp 1, and three copies of ATF/CREB sites, respectively. The DNA fragment encompassing the HIV sequence from -45 to +83, which contained the TATA box and the transcription start site of the viral genome, was amplified by polymerase chain reaction (PCR), using the 5'-and 3'-primers which contained the EcoR I and Hind III sites, respectively. The resultant PCR product was inserted into the EcoR l-Hind in sites of pUC119. To construct luciferase reporter plasmids, the Kpn \-EcoR I DNA fragments of pUCAP-1, pUCSpl, and pUCNFKB; and the HIV-1 DNA fragment with EcoR I and Hind III sites were inserted into the Kpn l-Hind in sites of PGV-B (Toyo Ink Co., Tokyo, Japan) containing the luciferase gene. The resultant plasmids were named pAPlHL, pNFKBHL, and pSplHL, respectively. The DNA fragment containing the Sma I-£coR I fragment of pUCATF/CREB was also inserted into the Sma l-Hind III sites of PGV-B with the HIV-1 DNA fragment, with EcoR I and Hind III sites, resulting in pATFHL.
The pVgalactosidase expression plasmid pCH 110 (Pharmacia LKB, Uppsala, Sweden) was used as an internal control for transfection efficiency.
Measurement of PKC activity Cultured cells (-5X1O
7 cells per dish) were left untreated or treated with 50 \iM of CDCA. At the end of each stimulation interval, cells were rinsed twice with ice-cold PBS, suspended in 0.5 ml of hypotonic buffer [(50 mM Tris-HCl, pH 7.4, 5 mM EDTA, 10 mM EGTA, 0.3% P-mercaptoethanol, lmM phenylmethylsulfonyl fluoride) (PMSF)], collected into a homogenizer tube with a tight-fitting pestle, and subsequently lyzed with 60 strokes at 1000 r.p.m. After low speed centrifuge to remove nuclei (1000 g, 5 min), the homogenates were ultracentrifuged at 100 000 g for 1 h. The supernatant was used as the cytosol fraction. The pellet (paniculate membrane fraction) was resuspended and solubilized in 250 uJ of the hypotonic buffer containing 1 % Triton X-100 at 4°C for 60 min. PKC activity in each fraction (25 |il) was assayed using the Amersham PKC assay kit (Amersham, Buckinghamshire, UK) according to the manufacturer's recommendation.
Preparation of nuclear extract
Cells were treated as indicated and nuclear extracts were prepared essentially as described previously (27) . In brief, the nuclei were suspended at 0-4°C in 15 uJ of 20 mM KCI, 20 mM Tris, pH 7.6, 0.2 mM EDTA, 1.5 mM MgCl 2 , 25% glycerol, 5 mM (5-mercaptoethanoI, and 0.5 mM PMSF. Then, 60 u. 1 of the same buffer containing 600 mM KCI was carefully added, and the nuclei were incubated for 30 min on ice. The nuclear debris was pelleted by centrifugation in an Eppendorf centrifuge for 15 min at 4°C, and the resultant supernatant was used as the nuclear extract in the present study. Protein concentrations were determined using a Pierce Protein Assay Kit (Pierce, Rockford, Illinois) according to the manufacturers' protocol.
Electrophoretic mobility shift assay (EMSA)
EMSA was carried out as previously described with minor modification (27) . In brief, the double-stranded oligonucleotide probes were end-labeled with [a-32 P]dCTP (Amersham) using the Klenow fragment of DNA polymerase I (TaKaRa, Kyoto, Japan), and unincorporated nucleotides were chromatographically separated with a Nick column (Amersham). The nuclear extracts (usually 2 ng per reaction) were incubated with 0.5 ng of 32 P-end-labeled probe oligonucleotides (~20 000 c.p.m.) in a 20->il reaction mixture for 15 min on ice. Each reaction mixture for AP-1 (28), NFKB (29) , ATF/CREB (30) , and Spl (31) contained 10 mM HEPES ( pH 7.6), 50 mM KCI, 5 mM MgCI 2 , 0.1 mM EDTA (pH 8.0), 5 mM dithiothreitol, 10% glycerol, I mg/ml bovine serum albumin, and 2 ng poly (dl-dC) (Pharmacia LKB); 20 mM HEPES (pH 8.4), 60 mM KCI, 1 mM dithiothreitol, 50 ug/ml bovine serum albumin, 8% Ficoll, and 2 ng poly (dl-dC); 50 mM Tns-HCl (pH 7.9), 60 mM KCI, 12.5 mM MgCl 2 , 1 mM EDTA (pH 8.0), 1 mM dithiothreitol, 20% glycerol, and 2 |ig poly (dl-dC); and 10 mM Tris-HCl (pH 7.5), 60 mM KCI, 1 mM EDTA (pH 8.0), 1 mM dithiothreitol, 1 mM PMSF, 50 ug/ml bovine serum albumin, 10% glycerol, and 4 ng poly (dA-dT) (Pharmacia LKB); respectively. The reaction mixture was then loaded onto a 4% nondenaturing polyacrylamide gel containing 0.25 XTBE. The gels were run at 350 V for 2 h and dried. Radioactivity on the membrane was quantified with the bio-imaging analyzer BAS-2000II (Fujix, Tokyo, Japan), and then results were visualized by autoradiography. The upper strand sequences of synthetic oligonucleotides containing AP-1, NFKB, CREB, and Spl recognition sequence were: 5'-CTCGAGGCTTGATGAGTCAGCCGGAAG-3 r (28); 5'-CTCGAGTTGAGGGGACTTTCCCAGGCG-3' (32), 5'-AGAGATTGCCTGACGTCAGAGAGCTAG-3' (33); and 5'-ACCGGGCGGGCGGGCTACCGGGCGGGCT-3' (31), respectively.
Transfection and luciferase assay
Transient transfection was performed as described previously (27) In brief, cells were plated in 6 cm diameter plastic culture dishes (IWAKI Glass, Funabashi, Japan) to 30-50% confluency, washed with PBS three times and medium was replaced with Opti-MEM medium (Gibco BRL). Plasmid cocktail was mixed with 20 \i\ of Lipofectin reagent (Gibco BRL) and added to the culture. After 12 h of incubation, the medium was replaced with fresh Ham's F12 or RPMII640 supplemented with 0.2% albumin hydrolysate, and culture was further continued in the presence and absence of various ligands for 24 h. After normalization of transfection efficiency by p-galactosidase expression, luciferase enzyme activity was determined essentially as described before (27) Statistical analysis Levels of significance for comparisons between samples were determined using Student's (-test distribution. Results were expressed as mean ± SE.
Results
Translocation of PKC by treatment with CDCA
It is known that fecal bile acids are chiefly composed of unconjugated DCA and LCA (34, 35) . In this study, since viability of cultured cells was strongly affected by treatment with high concentrations of DCA and LCA (i.e. ^50 |iM), we mainly used unconjugated CDCA instead. Colon epithelial cells are known to be exposed to high concentrations of fecal bile acids, which are comparable to the bile acid concentrations used in the present study (34) (35) (36) (37) .
LoVo cells were treated with 100 |iM of CDCA for the indicated time periods and PKC activity in the cytosol and membrane fractions were determined as described in Materials and methods. As shown in Figure 1 , cytosolic PKC activity was decreased after treatment with CDCA, while membrane PKC activity was increased, indicating that in LoVo cells CDCA significantly promoted translocation of PKC from the cytoplasm to the membrane. Effect of CDCA on AP-1 DNA binding activity We then analyzed AP-1 DNA binding activity after treatment of LoVo cells with CDCA in EMSA. LoVo cells were treated with 100 nM of CDCA or 10 nM of PMA for 2 and 6 h, and the nuclear extracts were prepared. After treatment with CDCA, the specific protein-DNA complex formed was increased in a time-dependent fashion ( Figure 2A, lanes 2-4) . The fact that Cl DNA binding activity represents AP-1, was confirmed by the following criteria. First, treatment with 10 nM of PMA induced Cl complex formation as well as CDCA (at least, the positions of the protein-DNA complexes were identical, Figure  2A) . Second, involvement of either anti-c-Fos or anti-c-Jun antibody in CDCA-and PMA-treated nuclear extracts clearly retarded the migration of Cl complexes and gave supershifted S complexes (Figure 2A, lanes 5, 6, 11, 12 ). In contrast, involvement of either anti-NFicB antibody or non-specific human immunoglobulin did not affect the migration of Cl (Figure 2A, lanes 7, 8, 13, 14) , strongly indicating that Cl complex contained c-Fos and c-Jun as protein components. The formation of another complex C2 was slightly influenced by either treatment with CDCA or PMA (Figure 2A) , while the effect of involvement of either c-Fos or c-Jun antibody was apparently different between Cl and C2 (Figure 2A ). This suggested that C2 represented other members of products from the fas and jun gene family. Figure 2B shows sequence specificity of the protein-DNA complexes formed between AP-1 probe and the nuclear extracts which were from the cells treated with either CDCA or PMA. Addition of unlabeled AP-1 oligonucleotides efficiently competed with those complex formations ( Figure 2B, lanes 2-5 and 9-12) . However, addition of unrelated oligonucleotides did not affect formation of either Cl or C2 protein-DNA complexes ( Figure 2B, lanes 6-8 and  13-15) . Together, CDCA induced AP-1 specific DNA binding activity in LoVo cells, the protein components of which were mainly c-Fos and c-Jun.
Next, we examined the effects of CDCA on DNA binding activity of other transcription factors. As demonstrated in Figure 3A , treatment of LoVo cells with 100 (iM of CDCA for 2 to 6 h did not result in significant alteration in nuclear DNA binding activity for either NFKB, Spl, or CREB, while treatment with either PMA or forskolin significantly enhanced the DNA activity of NFKB or CREB, respectively ( Figure  3B) . Thus, the effect of CDCA was suggested to be specific for induction of AP-1 DNA binding activity. 
Effects of bile acids on transcriptional activation of AP-1-inducible reporter gene
To address whether treatment with bile acids influences the activity of the AP-1-dependent promoter, a transient transfection assay was performed. After transfection into LoVo cells with a panel of the reporter plasmids including pAPHL ( Figure  4A) Figure 4B ). However, expression of either reporter construct for NFKB, Spl, or ATF/CREB (pNFicBHL, pSplHL and pATFHL, respectively) was not significantly affected by treatment with CDCA ( Figure 4B ). This strongly suggests that the effect of bile acids on gene expression is not universal, but rather specific for AP-1-inducible genes. Next, the effects of various bile acids on transactivational function of AP-1 were studied. The plasmid pAPHL was transfected into LoVo cells, and the cells were treated with various bile acids at the indicated concentrations for 24 h. As shown in Figure 4C , whichever bile acids were included in the medium, luciferase activity was increased in a concentration- dependent fashion (LCA revealed cytotoxicity at 50 or 100 uM, data not shown). When induction of luciferase activity was assessed at lower concentrations (e.g. 10 or 20 \iM), LCA appeared to be the strongest inducer, followed by CDCA, DCA, CA, and UDCA ( Figure 4C ). This rank order was also seen in the inducibility of AP-1 DNA binding activity by the corresponding bile acids (data not shown). 
Induction of AP-1 activity by bile acids in other colon cancer cell lines
To examine cell-type selectivity of the effects of bile acids on nuclear AP-1 activity, we performed EMSA using the nuclear extracts from LoVo, DLD-1, and COLO320DM cells after treatment with 100 | LiM of CDCA for 6 h.
AP-1 DNA binding activity, especially formation of Cl protein-DNA complexes, was significantly induced in both LoVo and DLD-1 cells, however, the nuclear extracts from COLO320DM cells had only C2-forming activity ( Figure 5A ). The formation of C2 protein-DNA complexes were marginally up-regulated after treatment of CDCA in each cell line ( Figure  5A ). Transcriptional activation of AP-1-inducible reporter plasmid pAPlHL was also observed in both LoVo and DLD-1 cells after treatment with 10 to 100 |iM of CDCA for 24 h ( Figure 5B ). On the other hand, luciferase activity was not significantly induced in COLO320DM cells after treatment with CDCA ( Figure 5B ).
Discussion
In the present study, we present evidence showing that bile acids induce AP-1 DNA-binding activity and augment AP-1-responsive gene expression in human cultured colon adenocarcinoma cells, without affecting the function of the transcription factors NFKB, Spl, and ATF/CREB. Time course experiments in EMSA suggest that the post-translational activation of preexisting AP-1 into DNA binding species is more likely man de novo synthesis of both c-Fos and c-Jun. The effect of bile acids on AP-1 activity appears to be relatively selective in colon adenocarcinoma cells, since AP-1 activity was not influenced by bile acids in a neuroendocrine-derived colon cancer cell line.
We report that in colon adenocarcinoma cells, treatment with bile acids translocates PKC from the cytoplasm to the membrane, however, the underlying mechanism is unknown. We speculate that bile acids, not as a non-specific detergent, but as a specific signal generator, translocate PKC from the cytoplasm to the membrane, as argued by Weinstein et al. (38) . Mechanistically, there are, among others, several possibilities for this effect of bile acids. As shown in several cell types, treatment with bile acids may increase cytoplasmic Ca 2+ concentration via as yet an unknown mechanism (39, 40) . Alternatively, it has been shown that in vitro, the bile acid analog fusidic acid can replace phosphatidylserine in the activation of PKC and activate phospholipase C (41) . Further studies, therefore, are clearly needed to identify a secondary signal which is generated after interaction between bile acids and cell membranes, and activates PKC.
Concerning AP-1-dependent transcription by bile acids used in the present study, it appears that induction activity is correlated with the hydrophobicity of bile acids (42) . Already, several biological responses to bile acids have been shown to be closely related to their hydrophobicity: histamine release from mast cells (39) ; transcriptional repression of cholesterol 7a-hydroxylase genes (43) ; and induction of MHC class I mRNA in hepatocytes (44) . It is of interest that, among others, increase in cytoplasmic Ca 2+ concentration is involved in these apparently disparate biological phenomena (39, 43, 45) .
In many cell types, activation of PKC by PMA is known to be linked with the following activation of a set of transcription factors including NFKB as well as AP-1 (46) . In the present study we present evidence that bile acids differentially affect activity of transcription factors after activation of PKC: they activate neither NFKB, CREB/ATF, nor Spl, but activate AP-1 exclusively. Recently, it has become known that PKC consists of several subfamilies (8) . Although they are structurally conserved, each member has distinct characteristics in the generation of nuclear signals after its activation (8) . For example, PKC-a can regulate AP-1 without affecting NFKB activity (47) . In contrast, PKC^ which is activated by phosphatidylserine and other acidic phospholipids, but not by Ca 2+ , phorbor esters, or DAG, induces activation of NFKB but not AP-1 (48). Thus, although further studies are clearly needed, it is strongly suggested that bile acids activate only a set of isoforms of PKC.
We and other researchers have shown that bile acids activate PKC in various cells including colonic epithelial cells and colon cancer cells (11-17,49), however, there are apparently contradictory reports concerning the role of bile acid-activated PKC in colon carcinogenesis. It has been reported that overexpression of PKCP decreases growth and induces differentiation in HT29 colon cancer cells (50) . Similar discrepancies between activation of PKC and/or AP-1 and carcinogenesis is reported in PC 12 cells, in which NGF induces the expression of both c-fos and c-jun, but leads to the arrest of cell division and induction of neuronal differentiation (51) . The activation of AP-1 is not always followed by cellular proliferation and tumorigenesis, and these results are at variance with tumor promotive activity of PKC and AP-1 in certain situations. In this line, established colon cancer cell lines may not be a suitable model for analysis of the role of bile acids in colon tumorigenesis. Indeed, in mouse embryo fibroblast C3H10T1/ 2, it is shown that deregulation of the PMA-induced cellular responses occurs in cells at various stages of tumor promotion, and might be associated with the transforming process (52) . In colon carcinogenesis, aberrant cryptic foci have recently been considered to be preneoplastic lesions (53) . Therefore, to further examine the role of bile acids on AP-1 induction and colon tumorigenesis, these preneoplastic tissues should be examined as well. For this reason, we are currently developing a more sensitive technique for the measurement of AP-1 activity, which will enable us to analyze small samples such as cryptic foci.
